Key result
Naoxintong capsule showed no statistically significant difference compared to Tongxinluo capsule in total effect and symptom improvement for stroke recovery.
Why the study?
Does Naoxintong capsule improve stroke recovery in patients with Qi-deficiency and blood-stasis syndrome compared to Tongxinluo capsule?
RCT
Double-blind
Randomized
Yes
Does Naoxintong capsule improve stroke recovery in patients with Qi-deficiency and blood-stasis syndrome compared to Tongxinluo capsule?
Naoxintong capsule is non-inferior to Tongxinluo capsule for stroke recovery in patients with Qi-deficiency and blood-stasis syndrome.
Naoxintong capsule provides a viable alternative for post-stroke Qi-deficiency blood-stasis recovery; extends RCT evidence for TCM options in cerebrovascular rehabilitation.
OBJECTIVE: To study the efficacy and safety of Naoxintong capsule treatment of stroke recovery with Qi-deficiency and blood-stasis syndrome (cerebral infarction), and to compared the non-inferiority analysis with the positive drug Tongxinluo capsule. METHOD: Taking Tongxinluo capsules as control, randomized, double-blind, controlled, multi-center clinical experiments were studied. The evaluating indexes included the decrease of integral value of stroke patients, changes in traditional Chinese medicine, the improvement of the patient viability status (disability level), Chinese stroke scale (CSS), activities of daily living (DAL) scale and barthel index (BI ) points. RESULT: The total effect of the two groups, Chinese and other symptoms, showed no significant statistical significance. CONCLUSION: Naoxintong capsule stroke recovery, with Qi-deficiency and blood-stasis syndrome (cerebral infarction) has a therapeutic effect, and more secure.
No takes yet. Share an insight, caveat, or question.
Liya Su (2011) conducted an RCT in Stroke recovery with Qi-deficiency and blood-stasis syndrome (cerebral infarction). Naoxintong capsule vs. Tongxinluo capsule was evaluated on Total effect, Chinese and other symptoms. Naoxintong capsule showed no statistically significant difference compared to Tongxinluo capsule in total effect and symptom improvement for stroke recovery.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: